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ABSTRACT
Objectives: To analyze the prognosis and related risk factors of patients with scarred uterus complicated with central 
placenta previa. 
Material and methods: A total of 272 parturient women admitted to our hospital between June 2013 and December 
2016 were selected, of whom 142 cases with central placenta previa were designated as a control group and another 130 with 
scarred uterus complicated with central placenta previa were allocated as an observation group. The delivery outcomes of 
the two groups were compared, and the influencing factors were comprehensively analyzed. 
Results: The prenatal and postpartum blood losses of the observation group were significantly higher than those of the 
control group (P < 0.05). The incidence rates of placental adhesion, placenta accreta, hysterectomy and puerperal infection 
in the obstetric group significantly exceeded those of the control group (P < 0.05). Logistic regression analysis showed that 
postpartum hemorrhage and placenta implantation were risk factors affecting prognosis (P < 0.05). 
Conclusions: Patients with scarred uterus and central placenta previa suffered from serious complications such as profuse 
postpartum hemorrhage and placental adhesion after delivery. Particular attention should be paid to women with scarred 
uterus during subsequent pregnancy to prevent placenta previa and to reduce the risks of delivery, thereby benefiting 
prognosis evaluation.
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INTRODUCTION
Most scarred uteri contain traumatic uterine scars 
caused by cesarean section. A woman with scarred uterus 
may be prone to uterine rupture or ectopic pregnancy dur-
ing subsequent pregnancy [1]. Pregnant women who have 
received cesarean sections are vulnerable to placenta pre-
via, being closely related to the number of surgeries [2, 3]. 
Cesarean section is an important measure to save lives 
when parturient women give birth. In recent years, the 
cesarean section rate has rapidly increased due to patient 
requirements or social factors, reaching over 20% in China. 
Central placenta previa is an extremely dangerous adverse 
pregnancy, also known as dangerous placenta previa if 
complicated with scarred uterus. These parturient women 
are often subjected to secondary pregnancy after receiv-
ing cesarean section that produces scars attaching the 
placenta. As a result, postpartum hemorrhage frequently 
occurs in clinical practice, endangering the life safety of 
mothers and infants [4]. Intrauterine bleeding during in-
duction of labor is the main problem, possibly leading to 
total hysterectomy which affects the reproductive functions 
of pregnant women and even severely threatens their life 
safety. For this type of pregnancy, prophylactic uterine 
artery embolization (UAE) or internal iliac artery balloon 
occlusion can be performed before delivery [5, 6]. UAE 
prior to induction of labor can elevate the success rate of 
surgery, decrease blood loss, relieve the injury to pregnant 
women, and shorten the time of postoperative menstrual 
relapse. Preoperative internal iliac artery balloon occlusion 
can effectively reduce the intraoperative bleeding, blood 
transfusion amount, and incidence rates of complications of 
cesarean section. Therefore, prenatal preventive measures 
are in need to improve maternal outcomes. The purpose 
of this study was to explore the prognosis of patients with 
scarred uterus complicated with central placenta previa 
and related influencing factors.
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MATERIALS AND METHODS
Baseline clinical data
This study has been approved by the ethics committee 
of our hospital, and written consent has been obtained from 
all patients. A total of 272 patients with central placenta 
previa admitted to our hospital from June 2013 to December 
2016 were selected as the subjects and diagnosed refer-
ring to the Guidelines for Diagnosis and Treatment of Pla-
centa Previa. Among them, 142 cases with central placenta 
previa were designated as a control group that was aged 
25–42 years old, (28.94 ± 3.26) on average. The gestational 
ages ranged from 28 to 41 weeks, (35.27 ± 2.13) on average. 
Besides, 90 cases had pregnancies ≤ twice and 52 cases un-
derwent pregnancies ≥ 3 times. In addition, 84 cases had in-
duced abortions < twice and 58 cases did so > 3 times. Mean-
while, 130 cases of scarred uterus complicated with central 
placenta previa were included as an observation group aged 
from 27 to 43 years old, with an average of (30.35 ± 4.74). The 
gestational ages ranged from 28 to 42 weeks, (35.89 ± 2.67) 
on average. Besides, 68 cases had pregnancies ≤ twice and 
62 cases underwent pregnancies ≥ 3 times. In addition, 
74 cases had induced abortions < twice and 56 cases did 
so > 3 times. The baseline clinical data of the two groups 
were similar (P > 0.05).
Inclusion criteria: The gestation cycle was over 28 weeks; 
Doppler color ultrasonography suggested that the placenta 
was obviously attached to the lower uterus; the placenta 
edge reached the cervix until full coverage. Exclusion crite-
ria: Pregnant women who were complicated with coagu-
lopathies, cardiovascular and cerebrovascular diseases, or 
chronic liver and kidney dysfunction.
Treatment methods
Patients diagnosed as scarred uterus complicated with 
central placenta previa all received cesarean section, and 
those with gestational ages < 34 weeks were administered 
with ritodrine to inhibit uterine contraction and with dexa-
methasone to promote fetal heart and lung maturation. In 
the meantime, fetal heart rate monitoring was performed, 
and vaginal bleeding was observed. The patients who were 
pregnant for at least 34 weeks were subjected to elective 
cesarean section. Immediately after delivery, 20 IU of oxy-
tocin and 250 μg of hemabate were injected into the fundus 
of uterus, and iodoform gauze was used to stop bleeding 
in the uterine cavity. Then the uterine cavity was packed 
with a balloon or bilateral uterine upper arterial branches 
were ligated. Catheterization was conducted through the 
iliac artery for UAE, and the lower uterine segment was 
subjected to annular narrowing suture. If the above treat-
ments all failed, whether hysterectomy was needed should 
be determined during surgery.
Observation indices
Prenatal and postpartum hemorrhages of the two 
groups were compared. The incidence rates of placental 
adhesion, placenta accreta and hysterectomy after delivery 
were recorded, and the risk factors affecting prognosis were 
analyzed. 
Statistical analysis
All data were analyzed by SPSS 21.0. The categorical 
data were expressed as mean ± standard deviation (x ± s), 
and inter-group comparisons were performed by the t test. 
The numerical data were expressed as percentage (%), and 
inter-group comparisons were conducted by the χ2 test. 
Factors affecting prognosis were subjected to Logistic 
multivariate regression analysis. P < 0.05 was considered 
statistically significant.
RESULTS
Prenatal and postpartum blood losses
The prenatal and postpartum blood losses of the ob-
servation group were significantly higher than those of the 
control group (P < 0.05) (Tab. 1).
Incidence rates of hysterectomy and 
complications
No patients died after delivery. The incidence rates of 
placental adhesion, placenta accreta, hysterectomy and 
puerperal infection in the obstetric group significantly ex-
ceeded those of the control group (P < 0.05) (Tab. 2).
Risk factors affecting prognosis
Logistic regression analysis showed that postpartum 
hemorrhage and placenta implantation were risk factors 
affecting prognosis (P < 0.05) (Tab. 3).
Table 1. Prenatal and postpartum blood losses
Group Case No. Prenatal blood loss [mL] Postpartum blood loss [mL] t value P value
Control 142 53.19 ± 17.34 473.26 ± 138.42 16.344 < 0.05
Observation 130 214.63 ± 50.27 652.48 ± 147.69 18.752 < 0.05
t value 11.864 12.267
P value < 0.05 < 0.05
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DISCUSSION
As an effective measure to save the risk of mother and 
infant, cesarean section has been widely used in clinical 
practice. In recent years, some parturient women have often 
abandoned natural production in order to alleviate the pain 
of childbirth, which makes the cesarean section rate increase 
year by year [7, 8]. Uterine scars caused by cesarean section 
are of serious risk to those who are pregnant again. Serious 
complications such as major bleeding and placenta previa 
are often caused during childbirth. If they cannot be rescued 
in time, the lives of both mother and fetus will be threatened. 
The results of related studies showed that China’s cesar-
ean section rate reached 21.7% in 2014, and the incidence 
of scarred uterus combined with placenta previa increased 
year by year, due to the damage of cesarean section to the 
endometrium and the occurrence of scars hinders the abil-
ity of the placenta to move up in the last trimester, thereby 
increasing the risk of placenta previa [9, 10]. The proportion 
of central placenta previa in women of childbearing age in 
China is about 2.3% [11], which is on the rise year by year. 
The cause of central placenta previa is closely related to 
multiple pregnancies, induced abortions, and cesarean sec-
tion. When sperm enters the damaged endometrium, the 
placenta needs to expand the volume continuously, and 
even extend to the lower part of the uterus so as to obtain 
adequate ingestion of nutrients because the blood cannot 
be supplied in time. By the last trimester, the placenta will 
cover the entire cervix and form a central placenta previa.
Scarred uterus combined with central placenta previa is 
a clinical phenomenon of placenta previa in the uterus after 
trauma, also known as sinister placenta previa, which has 
the highest mortality rate in the pregnancy risk syndromes 
[12]. In pregnant women with a history of cesarean section, 
the endometrium has degenerative lesions due to multi-
ple births, the endometrium at the scar is thinned and the 
contraction of the inner wall muscle weakened [12–14]. In 
addition, the villi can easily invade the uterine wall muscle, 
causing the implantation of placenta. And the scar is prone 
to uterine rupture and cause massive bleeding after being 
stretched, so that the woman has to undergo hysterectomy 
to save her life.
The results of this study showed that the amount of 
bleeding before and after delivery was significantly higher 
in the observation group than in the control group, which 
proves that the scarred uterus has a higher incidence of 
postpartum hemorrhage in parturient women. The inci-
dence rate of maternal placental adhesion, placental im-
plantation, puerperal infection and hysterectomy of the 
observation group was also significantly higher than that 
of the control group, which also indicates that the scarred 
uterus combined with central placenta previa is a serious 
risk of pregnancy. Analysis of the above factors by logistic 
regression model found that postpartum hemorrhage, pla-
cental implantation and hysterectomy were the main risk 
factors affecting the prognosis of parturient women with 
scarred uterus combined with central placenta previa. For 
many families planning re-pregnancy, it is necessary to 
prevent the occurrence of scarred uterus in order to prevent 
the occurrence of adverse events such as placenta previa. 
Medical staff must pay attention to avoiding abuse of ce-
sarean section and encourage pregnant women to choose 
natural delivery [15].
CONCLUSIONS
In summary, scarred uterus combined with central pla-
centa previa is likely to cause serious complications such 
as postpartum hemorrhage and placenta implantation, 
resulting in an increase in the rate of hysterectomy, which 
is an irreversible harm to women. Therefore, for such preg-
nant women, it is recommended to improve placental color 
Table 2. Incidence rates of hysterectomy and complications [case (%)]
Group Case No. Hysterectomy Placental adhesion Placenta accreta Puerperal infection
Control 142 2 22 8 6
Observation 130 10 24 12 8
χ2 value 11.752 10.756 11.283 9.674
P value < 0.05 < 0.05 < 0.05 < 0.05
Table 3. Risk factors affecting prognosis
Risk factor β value Wald value P value OR value 95% CI
Postpartum hemorrhage 0.623 65.248 < 0.05 0.352 0.238–0.527
Placenta accreta 0.147 7.136 < 0.05 1.084 1.034–3.803
Hysterectomy 1.815 5.27 < 0.05 1.291 0.898–4.726
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Doppler ultrasound or placental MR detection for definitive 
diagnosis during pregnancy of 28–32 weeks, pay attention 
to close monitoring during pregnancy, and give priority 
to all emergency-response measures, and strive to raise 
the maternal and infant survival rate and improve clinical 
prognosis.
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